MetaCap

Dyne Therapeutics Statistics

NASDAQ: DYNHealth CareBiotechnology: Pharmaceutical PreparationsUSD

15.50-0.53 (-3.31%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Dyne Therapeutics by the numbers

Dyne Therapeutics has a market capitalization of $2.90 billion based on 187.39M shares outstanding. With trailing EPS of $-3.62, Dyne Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 6.4% below its 50-day average and 19.6% below its 200-day average.

Average daily trading volume is 2.94M shares, or about $45.5 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

DYN valuation vs. peer median

DYN compared with the median of 8 peer companies
MetricDYNPeer medianDifference
Market cap$2.90B$3.02B-4%
Avg. volume2.94M3.01M-3%

Peer median across 8 companies: ACAD, LEGN, TLX, SLS, BHC, XERS, VKTX, ABCL.

Valuation

Price and trading

Previous close
16.03
Open
15.91
Day range
15.41 – 16.48
52-week range
14.00 – 27.31
52-week change
-26.82%
Beta
—
Volume
2.23M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
2.90B
Forward Pe
-4.30
Eps
-3.62
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
27.31
Week52 Low
14.00
Avg Volume
2.94M
Shares Outstanding
187.39M
Ma50
16.55
Ma200
19.27
Earnings Date
Nov 5, 2026
Pct From52w High
-43.23%
Pct From52w Low
10.71%

Related